Robuta

https://pure.fujita-hu.ac.jp/en/publications/nonpermissive-hla-dpb1-mismatch-increases-mortality-after-myeloab/ Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic... hla mismatch increases mortality unrelated https://galtec.ar/en/clinical-relevance-of-galectin-1-in-hematologic-malignancies-treated-with-non-myeloablative-hemopoietic-stem-cell-transplantation-2/ Clinical relevance of galectin-1 in hematologic malignancies treated with non-myeloablative... Mar 6, 2026 - We are translating our discoveries on galectins and their ligands into new opportunities to target therapies for cancer, autoimmunity, and chronic inflammatory... clinical relevance https://avesis.erciyes.edu.tr/yayin/478d6989-c181-4487-a8c7-6a888e462ce2/non-myeloablative-stem-cell-transplantation-for-the-treatment-of-haematologic-malignancies-and-metastatic-solid-tumours-a-single-centre-experience Non-myeloablative stem cell transplantation for the treatment of haematologic malignancies and... stem cell transplantation for the https://discovery.fiu.edu/display/pub232604 Mixed lymphohematopoietic chimerism in adult recipients following non-myeloablative therapy and... mixed chimerism adult